FI830360L - Topiska farmaceutiska kompositioner - Google Patents

Topiska farmaceutiska kompositioner

Info

Publication number
FI830360L
FI830360L FI830360A FI830360A FI830360L FI 830360 L FI830360 L FI 830360L FI 830360 A FI830360 A FI 830360A FI 830360 A FI830360 A FI 830360A FI 830360 L FI830360 L FI 830360L
Authority
FI
Finland
Prior art keywords
substances capable
topiska
pharmaceutical composition
inhibiting
lesions
Prior art date
Application number
FI830360A
Other languages
English (en)
Other versions
FI830360A7 (fi
FI830360A0 (fi
Inventor
David Frederick Horrobin
Julian Lieb
Original Assignee
Horrobin David F
Julian Lieb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Horrobin David F, Julian Lieb filed Critical Horrobin David F
Publication of FI830360A0 publication Critical patent/FI830360A0/fi
Publication of FI830360A7 publication Critical patent/FI830360A7/fi
Publication of FI830360L publication Critical patent/FI830360L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
FI830360A 1982-02-03 1983-02-02 Topiska farmaceutiska kompositioner FI830360L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34520482A 1982-02-03 1982-02-03

Publications (3)

Publication Number Publication Date
FI830360A0 FI830360A0 (fi) 1983-02-02
FI830360A7 FI830360A7 (fi) 1983-08-04
FI830360L true FI830360L (fi) 1983-08-04

Family

ID=23354027

Family Applications (1)

Application Number Title Priority Date Filing Date
FI830360A FI830360L (fi) 1982-02-03 1983-02-02 Topiska farmaceutiska kompositioner

Country Status (7)

Country Link
EP (1) EP0085579B1 (fi)
JP (1) JPH0714873B2 (fi)
AT (1) ATE26918T1 (fi)
AU (1) AU556817B2 (fi)
DE (1) DE3371282D1 (fi)
FI (1) FI830360L (fi)
ZA (1) ZA83685B (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194185B (it) * 1983-04-01 1988-09-14 Schiapparelli Farma Composizione per il trattamento dell'acne
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
JPS60130519A (ja) * 1983-12-16 1985-07-12 Terumo Corp 脂肪輸液剤
GB8420771D0 (en) * 1984-08-15 1984-09-19 Efamol Ltd Treatment of skin disorders
GB8524276D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
ZA875317B (en) * 1986-08-01 1988-01-25 Warner-Lambert Company Transdermal compositions
EP0289204B1 (en) * 1987-04-27 1991-07-17 Efamol Holdings Plc Lithium salt-containing pharmaceutical compositions
GB8719988D0 (en) * 1987-08-25 1987-09-30 Efamol Ltd Chemical compounds
US5225441A (en) * 1987-06-18 1993-07-06 Block Drug Company, Inc. Treatment of periodontal disease
EP0432700A3 (en) * 1987-08-25 1991-06-26 Efamol Holdings Plc Use of lithium compounds for the treatment of combination skin
JPH01135704A (ja) * 1987-11-18 1989-05-29 Medical Res Internatl Ltd 微生物を破壊する表面処理方法
GB8806737D0 (en) * 1988-03-22 1988-04-20 Efamol Holdings Therapeutic composition & method
AU616502B2 (en) * 1988-04-22 1991-10-31 Medvet Science Pty. Ltd. Treatment of inflammatory disorders in humans
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
GB9023701D0 (en) * 1990-10-31 1990-12-12 Efamol Holdings Medical treatment
GB9211229D0 (en) * 1992-05-27 1992-07-08 Efamol Holdings Fatty acid treatment
FR2694692B1 (fr) * 1992-08-13 1994-10-28 Thorel Jean Noel Préparation cosmétique de nutrition de la peau.
US7404967B2 (en) 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
US5756107A (en) * 1994-12-21 1998-05-26 Cosmederm Technologies Formulations and methods for reducing skin irritation
US5997852A (en) * 1995-01-18 1999-12-07 Taisho Pharmaceutical Co., Ltd. Remedy for dermatitis
FR2740335B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, de lithium, d'etain, de zinc, de manganese ou d'yttrium comme antagoniste de substance p
FR2740341B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau
FR2740342B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, de manganese, de lithium, d'etain, de zinc ou d'yttrium, de cobalt, de baryum, de strontium dans des compositions pharmaceutiques
WO2001049300A2 (en) * 1999-12-30 2001-07-12 Henderson Morley Research And Development Limited Combinations for the treatment of dna viral infections comprising a loop diuretic and lithium
JP4880813B2 (ja) * 2000-10-26 2012-02-22 第一三共株式会社 外用消炎鎮痛剤組成物
BR0204228A (pt) * 2001-02-20 2004-06-22 Randy Ziegler Métodos para melhorar os sintomas de uma psicose e de esquizofrenia e para triar moléculas de teste, e, composto orgânico
WO2003024484A1 (fr) * 2001-09-14 2003-03-27 Ono Pharmaceutical Co., Ltd. Medicaments pour traiter le prurit
EP1865972B1 (en) * 2005-03-23 2013-11-06 CHS Pharma, Inc. Treatment or prevention of cancer and precancerous disorders
EP1967187B1 (fr) * 2007-03-06 2011-04-06 Rachid Ennamany Composition à base de rutine et de L-lysine
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
JP2013521300A (ja) * 2010-03-03 2013-06-10 ネオキュティス エスアー 抗菌ペプチド隔離化合物を用いた皮膚疾患および皮膚障害の処置のための組成物および方法
EP2708230B1 (en) 2011-05-12 2024-10-02 Nissui Corporation Composition for external skin use for inflammatory diseases
CN114410374B (zh) 2013-12-04 2025-01-07 株式会社日水 微生物油、微生物油的制造方法、浓缩微生物油及浓缩微生物油的制造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639625A (en) * 1967-07-13 1972-02-01 Lewis Sherwin Compositions containing lithium succinate
IE47777B1 (en) * 1978-01-23 1984-06-13 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
EP0012115A1 (de) * 1978-12-04 1980-06-11 Ciba-Geigy Ag Pharmazeutische Präparate zur topischen Behandlung von Virusinfektionen
JPS5659710A (en) * 1979-10-22 1981-05-23 Eisai Co Ltd Preventive and remedy for psoriasis
JPS56125313A (en) * 1980-03-09 1981-10-01 Lion Corp Remedy for damage
JPS56125312A (en) * 1980-03-09 1981-10-01 Lion Corp Remedy for damage
JPH0233013B2 (ja) * 1980-03-21 1990-07-25 Masatoshi Fumiiri Sokonchiryozai
JPS56161323A (en) * 1980-05-14 1981-12-11 Hisamitsu Pharmaceut Co Inc Anti-inflammatory and pain-killing gel
US4328243A (en) * 1981-04-07 1982-05-04 Horrobin David F Manic-depressive illnesses
US4386072A (en) * 1981-06-26 1983-05-31 Horrobin David F Treatment of disorders of inflammation and immunity and disorders associated with smooth muscle spasm and compositions therefor

Also Published As

Publication number Publication date
FI830360A7 (fi) 1983-08-04
FI830360A0 (fi) 1983-02-02
EP0085579A3 (en) 1984-02-29
ZA83685B (en) 1984-04-25
EP0085579A2 (en) 1983-08-10
JPH0714873B2 (ja) 1995-02-22
EP0085579B1 (en) 1987-05-06
AU1087583A (en) 1983-08-11
DE3371282D1 (en) 1987-06-11
ATE26918T1 (de) 1987-05-15
AU556817B2 (en) 1986-11-20
JPS58208217A (ja) 1983-12-03

Similar Documents

Publication Publication Date Title
FI830360A0 (fi) Topiska farmaceutiska kompositioner
ES482778A0 (es) Un procedimiento para la preparacion de una composicion u- til en el tratamiento de la epidermis.
IT8019118A0 (it) Apparecchio manuale per la cura o il trattamento dei denti.
SE8902377D0 (sv) Foerfarande foer framstaellning av ett vaevnadsbindemedel
BR8008183A (pt) Composicao de creme dental
ES8102141A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7
ZA90966B (en) Oxidized diphenylheteroalkanes,the preparation and use thereof
ATE127020T1 (de) Pharmazeutische zusammensetzungen mit eierschalenbestandteilen und ihre herstellung und verwendung.
JPS57122085A (en) Circulatory disease extirpenter and use
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
ATE5073T1 (de) 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE2746T1 (de) Piperidinderivate von 4,5-dialkyl-3-hydroxypyrrol-2-carbons[ureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
FR2336945A1 (fr) Composition pour la sterilisation des femmes et des femelles d'animaux
NO153102C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv 9 alfa, 11 beta-diklor-16 alfa-methyl-21-oxycarbonyldicyclohexyl-methyloxypregna-1,4-dien-3,20-dion.
DE3174977D1 (en) Bioactive composition containing vegetable agents
GB2060638B (en) Lysine and arginine 5-(2,4-difluorophenyl)-2-hydroxybenzoic acid salts pharmaceutical compositions containing them and their use
JPS5585518A (en) Bile secretionnactive organism and therapeutic composition containing it as active ingredient
BE868956A (fr) Composition destinee au traitement de l'hypocalcemie, et de l'hypophosphatemie chez les animaux
IT7921153A0 (it) Prodotti microbicidi e procedimento per la loro preparazione.
ATE9700T1 (de) (n-phosphonoacetyl-l-aspartato) (1,2diaminocyclohexan)-platin (ii) und natrium-, kalium- oder lithiumsalze, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
IT1166217B (it) Composizione farmaceutica per la terapia delle sterilita' maschile
RO80227A2 (ro) Medicament utilizat in profilaxia retentiilor placentare nespecifice la taurine
ES267419Y (es) "nuevo pie para maquinas recreativas de salon".

Legal Events

Date Code Title Description
FC Application refused

Owner name: E FAMOL LIMITED